Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4470385

O=C(O)C(F)(F)F.O=Cc1ccccc1-c1ccc(-c2c[nH]c(COc3ccccc3)n2)cc1

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 7/20 0.36
FFAR1 O14842 5/20 0.36
XDH P47989 1/20 0.34
HDAC1 Q13547 2/20 0.34
HDAC2 Q92769 2/20 0.34
MCL1 Q07820 2/20 0.33
ACACA Q13085 2/20 0.33
HDAC3 O15379 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC7 Q8WUI4 1/20 0.33
HDAC10 Q969S8 1/20 0.33
HDAC11 Q96DB2 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
HDAC9 Q9UKV0 1/20 0.33
HDAC5 Q9UQL6 1/20 0.33
PPARG P37231 1/20 0.32
PPARA Q07869 1/20 0.32
DAO P14920 1/20 0.32
RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4685013 0.92 XDH (0.40) XDHMCL1ACACADAORAB9A
Trifluoroacetic Acid SCHEMBL4460353 0.84 MCL1 (0.47) FFAR4FFAR1XDHHDAC1HDAC2
Trifluoroacetic Acid SCHEMBL4470387 0.82 PPARG (0.41) MCL1PPARGPPARARAB9A
Trifluoroacetic Acid SCHEMBL4458367 0.80 MCL1 (0.48) FFAR4FFAR1XDHHDAC1HDAC2
Formaldehyde SCHEMBL4470383 0.79 FFAR4 (0.39) FFAR4FFAR1MCL1ACACA
Trifluoroacetic Acid SCHEMBL8216241 0.76 HDAC3 (0.40) HDAC1HDAC2MCL1HDAC3HDAC4
SCHEMBL4681552 0.76 NR4A2 (0.49) MCL1RAB9A
SCHEMBL5750527 0.75 LMNA (0.44) XDHMCL1HDAC6DAORAB9A
Trifluoroacetic Acid SCHEMBL4456741 0.75 MEN1 (0.57) RAB9A
SCHEMBL4466562 0.75 RAB9A (0.45) XDHMCL1DAORAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7534805-B2 Imidazole derivatives, their preparation and their use as medicaments SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 2009-05-19 US claimed
EP-1638943-B1 NOVEL IMIDAZOLE DERIVATIVES, THE PRODUCTION THEREOF, AND THE USE OF THE SAME AS A MEDICAMENT SOD CONSEILS RECH APPLIC (FR) 2008-08-06 EP claimed
US-20070066542-A1 Novel imidazole derivatives, their preparation and their use as medicaments SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATION SCIENTIFIQUES (S.C.R.A.S.) (FR) 2007-03-22 US claimed
US-7534805-B2 Imidazole derivatives, their preparation and their use as medicaments SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 2009-05-19 US disclosed
US-20070066542-A1 Novel imidazole derivatives, their preparation and their use as medicaments SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATION SCIENTIFIQUES (S.C.R.A.S.) (FR) 2007-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070066542-A1 Novel imidazole derivatives, their preparation and their use as medicaments MIF, MCL1, PPIP5K2 FFAR4 4653/4885FFAR1 4638/4885XDH 375/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.